Stocktoria
Bangkok Dusit Medical Services Public Company Limited BDMS.BK
TH · Stock Exchange of Thailand · XBKK · stock · Healthcare · website
Bangkok Dusit Medical Services Public Company Limited financials (annual, from 10-K)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $111.5B | $107.9B | $100.9B | $91.9B |
| Gross profit | $40.2B | $39.8B | $37.4B | $33.6B |
| SG&A expense | $21.8B | $20.8B | $19.8B | $17.7B |
| Operating income | $20.2B | $20.5B | $18.9B | $17.0B |
| Interest expense | $356.6M | $433.4M | $546.6M | $632.1M |
| Income tax | $3.7B | $3.8B | $3.8B | $3.2B |
| Net income | $15.8B | $16.0B | $14.4B | $12.6B |
| EPS (diluted) | $1.00 | $1.01 | $0.90 | $0.79 |
| Operating cash flow | $23.4B | $23.0B | $20.8B | $20.3B |
| Free cash flow | $12.0B | $11.3B | $12.5B | $15.2B |
| Cash & equivalents | $6.3B | $7.4B | $7.8B | $12.7B |
| Inventory | $3.4B | $2.6B | $2.4B | $2.2B |
| Total assets | $158.0B | $151.5B | $143.8B | $141.7B |
| Total liabilities | $48.0B | $47.6B | $44.7B | $47.8B |
| Shareholders' equity | $105.9B | $100.0B | $95.4B | $90.1B |
Growth · year-over-year · Revenue CAGR 6.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +3.4% | +7.0% | +9.7% | — |
| Net income growth | -0.9% | +11.3% | +13.9% | — |
| EPS growth | -1.0% | +12.2% | +13.9% | — |
| Free cash flow growth | +6.6% | -10.0% | -17.6% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · TH · as of 2025-12-31. Figures in THB; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.